Competitive antagonists shift the dose-effect curve for an agonist (e.g. the endogenous neurotransmitter) to the right, but this effect can eventually be overcome by enough agonist concentration.
Related content
What are the recent innovations in the pharmacological treatment of schizophrenia?
Professor Dr. Christoph Correll highlights the recent innovations in the pharmacological treatment of schizophrenia.
17.04.2026
Schizophrenia
The impact of anxiety disorders on suicide
Suicidal ideation is far more common than attempts in people with anxiety or depression, especially with comorbid disorders and severe depression.
08.04.2026
Anxiety Disorders
